Isopropylamine → 14′-Cyclohexyl-1-(1-methylethyl)spiro[azetidine-3,7′(8′H)-[6H]indolo[1,2-e][1,5]benzoxazocine]-11′-carboxylic acid
Reaction equation
O.C1(C)C=CC(S(O)(=O)=O)=CC=1.S(OS(C(F)(F)F)(=O)=O)(C(F)(F)F)(=O)=O.[CH:28]1([C:34]2[C:35]3[CH:36]=[CH:37][C:38]([C:57]([O:59]C)=[O:58])=[CH:39][C:40]=3[N:41]3[C:48]=2[C:47]2[CH:49]=[CH:50][CH:51]=[CH:52][C:46]=2[O:45][CH2:44][C:43]([CH2:55]O)([CH2:53]O)[CH2:42]3)[CH2:33][CH2:32][CH2:31][CH2:30][CH2:29]1.CC[N:63](C(C)C)[CH:64]([CH3:66])[CH3:65].C(N)(C)C>CO.C1COCC1.CC#N.CCOC(C)=O>[CH:28]1([C:34]2[C:35]3[CH:36]=[CH:37][C:38]([C:57]([OH:59])=[O:58])=[CH:39][C:40]=3[N:41]3[C:48]=2[C:47]2[CH:49]=[CH:50][CH:51]=[CH:52][C:46]=2[O:45][CH2:44][C:43]2([CH2:53][N:63]([CH:64]([CH3:66])[CH3:65])[CH2:55]2)[CH2:42]3)[CH2:29][CH2:30][CH2:31][CH2:32][CH2:33]1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 3
Procedure
A catalytic amount of para-toluenesulfonic acid monohydrate was added to a suspension of methyl 14′-cyclohexyl-2,2-dimethylspiro[1,3-dioxane-5,7′-indolo[1,2e][1,5]benzoxazocine]-11′-carboxylate in MeOH/THF 1:2 (0.03 M), and the solution was stirred for 3 h at RT. Filtration over a pad of neutral alumina with EtOAc afforded after evaporation of the solvent in vacuo, methyl 14-cyclohexyl-7,7-bis(hydroxymethyl)-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylate (quant). Triflic anhydride (2.8 eq) was added at 0° C. to a solution of methyl 14-cyclohexyl-7,7-bis(hydroxymethyl)-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylate in dry MeCN (0.05M), DIPEA (3.0 eq) was added and the mixture was stirred for 15 min at 0° C., then further 3.0 eq of DIPEA were added, followed by iPrNH2 (2 eq). The mixture was transferred into a closed vessel and stirring was continued at 70° C. for 4 h. EtOAc was added, the organic phase was washed with water and brine, dried over Na2SO4 and the solvent was removed in vacuo. The residue was hydrolysed with aqueous 1N KOH in dioxane (65° C., overnight); evaporation to dryness gave a residue that was purified by RP-HPLC to afford the title compound (4%). 1H NMR (300 MHz, DMSO-d6, 330 K) δ 8.50 (s, 1H), 7.87 (d, 1H, J 8.3), 7.70 (d, 1H, J 8.3), 7.51-7.46 (m, 1H), 7.24-7.15 (m, 3H), 5.16 (b.d, 1H, J 15.9), 4.28 (d, 1H, J 12.7), 4.20 (d, 1H, J 12.7), 4.1-3.5 (m, 6H), 2.75-2.66 (m, 1H), 2.01-1.58 (m, 7H), 1.39-1.17 (m, 9H); MS (ES+) m/z 459 (M+H)+.
Workup
- filtrationFiltration over a pad of neutral alumina with EtOAc
- customafforded
- customafter evaporation of the solvent in vacuo, methyl 14-cyclohexyl-7,7-bis(hydroxymethyl)-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylate (quant)
- additionwas added
- stirringthe mixture was stirred for 15 min at 0° C.
- customThe mixture was transferred into a closed vessel
- stirringstirring
- waitwas continued at 70° C. for 4 h
- washthe organic phase was washed with water and brine
- dry with materialdried over Na2SO4
- customthe solvent was removed in vacuo
- customwas hydrolysed with aqueous 1N KOH in dioxane (65° C., overnight)
- customevaporation to dryness
- customgave a residue that
- customwas purified by RP-HPLC
Sources & evidence
- ORD record
- ord-3ec543dd7a3d40278dfb60fd859e91ae
- Source dataset
- uspto-grants-2012_07
- Patent number
- US08232390B2
Reaction notes
Loading…